Age-adjusted mortality rates for type 2 diabetes mellitus in the United States increased substantially between 1999 and 2025 and are projected to continue climbing through 2035, according to an ecological time-series analysis. Drawing on the CDC WONDER Multiple Cause of Death database, researchers evaluated 2,334,931 death records where type 2 diabetes (ICD-10 code E11) was recorded on death certificates. Across the full study window, the nationwide age-adjusted mortality rate climbed from 21.51 deaths per 100,000 individuals in 1999 to 56.27 deaths per 100,000 individuals in 2025, with figures for 2025 remaining provisional. This overall upward trajectory represented a statistically significant average annual percent change of 3.44 percent (95% confidence interval: 2.11 to 4.78 percent; p < 0.001).
The longitudinal analysis revealed distinct phases in mortality trends over the twenty-six-year observation interval, assessed using Joinpoint regression models. Overall rates experienced an initial upward climb from 1999 to 2005 before leveling into a stable period that lasted through 2015. Beginning after 2015, mortality rose sharply to reach a peak in 2021, which was subsequently followed by a modest decline extending through 2025. While prevalence of the condition is well tracked nationwide, demographically detailed mortality trends and projections have remained limited, prompting the researchers to investigate how mortality burdens shifted across different demographic groups and geographic regions over time.
Demographic evaluations identified marked and persistent disparities across sex, age, and race and ethnicity throughout the observed historical window. Age-adjusted mortality rates were consistently higher among men than women, with the highest mortality rates concentrated among older adults aged 65 to 85 and older. Among racial and ethnic groups, the greatest mortality rates occurred among non-Hispanic American Indian and Alaska Native adults. Elevated mortality rates were also observed at comparable levels among Hispanic or Latino adults and non-Hispanic Black adults, underscoring uneven distributions of disease burden across distinct segments of the United States population.
Geographic and place-based analyses demonstrated clear contrasts across United States census regions, states, places of death, and degrees of urbanization. When examining regional distributions and population density, the highest mean age-adjusted mortality rates were documented in the West census region and in non-metropolitan areas. In addition to examining historical patterns, the authors treated urbanization projections as a sensitivity analysis because the underlying urbanization data available for the modeling ended in 2020.
To project future mortality through 2035, the investigators generated forecasts using an ensemble of two Holt exponential-smoothing specifications calibrated to the pre-pandemic window spanning 2008 to 2019. Projections for racial and ethnic groups and census regions were constrained to remain coherent with the national forecast utilizing the product-ratio method. The ensemble model projects that the national age-adjusted mortality rate will reach 67.03 per 100,000 by 2035, which is approximately 19 percent higher than the rate observed in 2025. The projection features a 95 percent model-based prediction interval of 57.57 to 76.48 and an empirically calibrated 95 percent upper bound of 148.17, with the projected trajectory resuming below the 2025 observation. By 2035, the highest projected age-adjusted mortality rates are expected among non-Hispanic American Indian and Alaska Native adults at 115.94 per 100,000 and in the West census region at 88.79 per 100,000.
The study authors concluded that type 2 diabetes mellitus continues to represent a major contributor to premature illness and death in the United States, marked by rising overall mortality and deep-seated demographic and geographic inequalities. The persistent disparities identify specific populations bearing a disproportionate and growing disease burden. In addressing these documented patterns, the researchers noted that earlier prevention efforts, stronger control of risk factors, and more equitable access to cardio-protective and reno-protective therapies represent critical priorities.
Subject of Research: Type 2 diabetes mortality trends and projections in the United States
Article Title: Trends and projected inequalities in type 2 diabetes mellitus mortality in the United States, 1999–2025, with projections to 2035: A CDC WONDER multiple cause of death analysis
Article References: Atif, E., Ahmad, A., Ali, M., Hassan, M. A., Das, V., Ahmad, D., Fatima, K., Mukhlis, M., Zahid, M. D., Qazi, S., Mazhar, M. A., & Obeidat, A. (2026). Trends and projected inequalities in type 2 diabetes mellitus mortality in the United States, 1999–2025, with projections to 2035: A CDC WONDER multiple cause of death analysis. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/s13098-026-02309-7
Image Credits: AI Generated
DOI: 10.1186/s13098-026-02309-7
Keywords: type 2 diabetes, mortality trends, public health, CDC WONDER, epidemiology, health disparities, United States, Trends, projected, inequalities, type, diabetes
News Source: Phoebe Ingram. (November 8, 2026). US Type 2 Diabetes Mortality Projected to Rise Through 2035. Scienmag.



